Practical implication
The program will implement collaborative processes for the evaluation of technologies, enhancing real-world evidence integration into signal management and impacting regulatory compliance workflows.
The Medicines and Healthcare products Regulatory Agency (MHRA) and Manchester University NHS Foundation Trust (MFT) have launched a new partnership to create a health innovation sandbox aimed at testing innovative technologies within the NHS. This initiative seeks to rapidly evaluate healthcare solutions that can improve patient care, safety, and access to new technologies, particularly focusing on AI-enabled medical devices.
What changed: A partnership was established to create a health innovation sandbox which will allow innovative technologies to be deployed and tested in NHS settings, generating evidence on their effectiveness and safety.
Why it matters: This partnership aims to address the challenge of proving new technologies work effectively in real healthcare environments, facilitating earlier diagnosis and personalized care for patients while enhancing the safety assessment processes within the NHS.
Practical implication: The program will implement collaborative processes for the evaluation of technologies, enhancing real-world evidence integration into signal management and impacting regulatory compliance workflows.
View original source
- Source: MHRA - News and communications
- Published at source: 2026-09-02T00:00:00.000Z
- Discovered by monitor: 2026-09-02T22:00:55.696Z
Published from the regulator source ingestion pipeline after PV impact triage.
